State Street Corporation 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-22 11:43 am Sale | 2023-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | STATE STREET CORP STT | 3,231,411 3.580% | -747,574 (-18.79%) | Filing |
| 2023-01-31 10:47 am Purchase | 2022-12-31 | 13G | Rocket Pharmaceuticals, Inc. RCKT | STATE STREET CORP STT | 3,978,985 5.050% | 3,978,985 (New Position) | Filing |